(Q53455197)

14 May 2018

title

Role of the INK4a locus in tumor suppression and cell mortality. (English)

1 reference

14 May 2018

1 reference

14 May 2018

author name string

Lee H

1 reference

14 May 2018

Chin L

1 reference

14 May 2018

Cordon-Cardo C

1 reference

14 May 2018

Beach D

1 reference

14 May 2018

DePinho RA

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 April 1996

1 reference

14 May 2018

published in

Cell

1 reference

14 May 2018

volume

1 reference

14 May 2018

issue

1 reference

14 May 2018

page(s)

27-37

1 reference

14 May 2018

Malignant melanoma in transgenic mice.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Requirement for a functional Rb-1 gene in murine development

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

CDC25 phosphatases as potential human oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

High Frequency of Chromosome 9p Allelic Loss and CDKN2 Tumor Suppressor Gene Alterations in Squamous Cell Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Cooperation between oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Germline p16 mutations in familial melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Effects of an Rb mutation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Spontaneous immortalization rate of cultured Chinese hamster cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Growth suppression by p16ink4 requires functional retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

A novel cyclin encoded by a bcl1-linked candidate oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Mutations and altered expression of p16INK4 in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Deletion of the p16 and p15 Genes in Human Bladder Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Inhibition of ras-induced proliferation and cellular transformation by p16INK4.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

1 reference

7 January 2021

D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981079-X

7 January 2021

10.1016/S0092-8674(00)81079-X

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018